Tom Miller, Ph.D., joined the Veracyte board of directors in September 2024, and the Veracyte Scientific and Technology Advisory Board in July 2026. Dr. Miller is a scientist and entrepreneur with a focus on the nexus of AI, chemistry, and biology.
Since 2020, he has served as Co-founder and Chief Executive Officer of Iambic Therapeutics, a clinical-stage biotechnology company that is disrupting the therapeutics landscape with a unique, AI-driven, drug-discovery platform.
Prior to this, he served over 10 years as a professor at the California Institute of Technology (Caltech), receiving tenure, publishing over 140 peer-reviewed articles and patents and receiving numerous awards for research and entrepreneurial excellence.
Dr. Miller earned a B.S. in Chemistry and Mathematics from Texas A&M University and a Ph.D. in Theoretical Chemistry from the University of Oxford.